Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  siplizumab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-3 of 3 for your search:
Start Over
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 65 and under
Sponsor: Other
Protocol IDs: 02-163, NCT00113646
Phase I Study of Siplizumab (MEDI-507) in Patients With CD2-Positive Lymphoproliferative Disorders
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-04-C-0031, MEDIMMUNE-MI-CP094, NCT00075361
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 090065, 09-C-0065, NCT01445535
Start Over